[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Vistra Corp. (VST) Form 144 notice reports proposed sale of 21,362 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $4,503,715.06. The filer indicates these shares were acquired under stock options originally granted on 10/11/2016 (19,200 shares) and 04/09/2018 (2,162 shares), with payment noted as cash on 09/22/2025. The filing also lists prior sales by the same person, totaling 190,847 common shares across eight transactions dated 09/10/2025–09/19/2025, with aggregated gross proceeds disclosed for each sale. The notice contains the filer’s representation that they are unaware of undisclosed material adverse information about the issuer.

Positive

• Complete disclosure of acquisition origins: option grant dates (10/11/2016 and 04/09/2018) are provided
• Brokered execution: proposed sale routed through Fidelity Brokerage Services LLC on the NYSE
• Recent sales documented: eight prior transactions are fully listed with gross proceeds

Negative

• Insider liquidity activity: 190,847 shares sold across 09/10/2025–09/19/2025 which may indicate ongoing monetization
• Concentration of sales in a short period: multiple consecutive trading dates could attract investor attention

Insights

Securities Analyst

TL;DR: Insider exercises/options sales disclosed; amounts are small relative to shares outstanding, indicating routine monetization rather than control change.

The Form 144 documents a proposed sale of 21,362 shares via a broker and records recent open-market sales totaling 190,847 shares over consecutive dates. The shares to be sold were acquired via previously granted options in 2016 and 2018 and paid in cash on the stated sale date. Compared with the reported outstanding share count of 338,820,324, the transactions represent a de minimis fraction of equity, suggesting limited immediate impact on capitalization. Filings are clear about acquisition dates, nature of acquisition, broker, and per-transaction proceeds, supporting standard disclosure practices.

Corporate Governance Expert

TL;DR: Routine insider sales disclosed with required certifications; no governance red flags present in the text.

The notice includes the required signer representation regarding absence of undisclosed material adverse information and lists trade execution through a recognized brokerage firm. The seller’s sales history is fully enumerated with dates and gross proceeds for each transaction within the recent period. There is no indication in this document of related-party transfers, gifts, or nonstandard consideration structures. From a governance disclosure standpoint, the filing meets Rule 144 reporting elements shown in the content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21362	4503715.06	338820324	09/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/22/2025	Option Granted - 10/11/2016	Issuer			19200	09/22/2025	Cash
Common	09/22/2025	Option Granted - 04/09/2018	Issuer			2162	09/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/10/2025	19592	3933635.75
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/11/2025	43074	8991625.77
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/12/2025	21374	4335603.72
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/15/2025	21362	4481773.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/16/2025	21358	4565882.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/17/2025	21361	4540506.03
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/18/2025	21366	4554708.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/19/2025	21360	4517570.62

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Vistra Corp. (VST) Form 144 report?

The Form 144 reports a proposed sale of 21,362 common shares through Fidelity Brokerage Services with aggregate market value of $4,503,715.06 and prior open-market sales totaling 190,847 shares.

How were the shares acquired that are being sold?

The shares to be sold were acquired via options: 19,200 shares from an option granted 10/11/2016 and 2,162 shares from an option granted 04/09/2018.

Through which broker and exchange will the proposed sale occur?

The filing lists Fidelity Brokerage Services LLC and indicates the securities exchange as NYSE.

How many shares has the filer sold in the recent reporting period?

The filing lists eight sales from 09/10/2025 to 09/19/2025 totaling 190,847 common shares with gross proceeds disclosed per transaction.

What fraction of outstanding shares does the proposed sale represent?

The proposed sale of 21,362 shares is shown alongside 338,820,324 shares outstanding; the sale is a de minimis fraction of outstanding shares based on those figures.